Advanced imaging uncovers that glioblastoma affects the skull and immune system, not just the brain.
Key Details
- 1Montefiore Einstein researchers found glioblastoma erodes skull bones and alters skull marrow immune makeup.
- 2CT imaging of patients showed similar skull erosions as seen in mouse models with glioblastoma.
- 3Single-cell RNA sequencing revealed a shift toward pro-inflammatory immune cells in the skull marrow.
- 4FDA-approved osteoporosis drugs halted skull erosion but made tumors more aggressive and impaired immunotherapy effects.
- 5Findings suggest glioblastoma should be seen as a systemic, not just local, disease.
Why It Matters
These findings highlight the need for radiologists to consider extracranial effects when imaging glioblastoma and suggest that traditional local-treatment approaches may overlook critical systemic interactions. Understanding these effects can influence both diagnostic imaging strategies and future treatment planning.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.